A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
Completed · Phase 3 · Has a placebo group
Conditions studied: Alzheimer´s Disease
In brief
The purpose of this study was to evaluate the efficacy and safety of 2 doses of Immune Globulin Intravenous (IGIV), 10% administered every 2 weeks as an intravenous (IV) infusion compared with placebo in participants with mild to moderate Alzheimer's disease (AD).
Key facts
- Study ID
- NCT00818662
- Run by
- Baxalta now part of Shire
- People needed
- 390
- Starts
- 2008-12-19
- Expected to finish
- 2012-12-10
- Last updated by the study team
- 2021-05-19
Who can join
Age: 50 and older, up to 89. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — Birmingham, Alabama, United States
- Study site — Phoenix, Arizona, United States
- Study site — Sun City, Arizona, United States
- Study site — Tucson, Arizona, United States
- Study site — Irvine, California, United States
- Study site — La Jolla, California, United States
- Study site — Los Angeles, California, United States
- Study site — National City, California, United States
- Study site — Orange, California, United States
- Study site — New Haven, Connecticut, United States
- Study site — Washington D.C., District of Columbia, United States
- Study site — Miami Beach, Florida, United States
- Study site — Sarasota, Florida, United States
- Study site — Tampa, Florida, United States
- Study site — Chicago, Illinois, United States
- Study site — Iowa City, Iowa, United States
- Study site — Kansas City, Kansas, United States
- Study site — Lexington, Kentucky, United States
- Study site — Burlington, Massachusetts, United States
- Study site — Paw Paw, Michigan, United States
- Study site — Rochester, Minnesota, United States
- Study site — St Louis, Missouri, United States
- Study site — Omaha, Nebraska, United States
- Study site — Las Vegas, Nevada, United States
- Study site — Liverpool, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.